Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 28 results:
Author Title Type [ Year] Filters: Keyword is Papillomavirus Infections [Clear All Filters]
Human papilloma virus vaccination and attitudes towards contraception: a cross-sectional study..
Eur J Contracept Reprod Health Care. 24(3), 182-187.
(2019).
(2018).
Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer..
Tumour Biol. 39(4), 1010428317697557.
(2017).
(2017). Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening..
Gynecol Oncol. 142(1), 120-127.
(2016). Cytokines of Cervical Mucosa and Human Papilloma Virus Infection of the Cervix: A Descriptive Study..
Acta Cytol. 60(1), 58-64.
(2016). Detection of human papillomavirus DNA in esophageal carcinoma in Greece..
World J Gastroenterol. 21(8), 2352-7.
(2015). Distinct demographic factors influence the acceptance of vaccination against HPV..
Arch Gynecol Obstet. 292(1), 197-205.
(2015).
(2015). Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study..
Eur J Cancer Prev. 23(5), 425-31.
(2014). Expression of HPV-related biomarkers and grade of cervical intraepithelial lesion at treatment..
Acta Obstet Gynecol Scand. 93(2), 194-200.
(2014).
(2014).
(2014). Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype..
Ann Oncol. 24(8), 2124-31.
(2013). Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva..
Eur J Cancer. 49(16), 3450-61.
(2013). Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine..
Arch Gynecol Obstet. 285(6), 1719-24.
(2012). The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples..
Int J Gynecol Cancer. 21(1), 79-85.
(2011). Human papillomavirus and cervical screening: misconceptions undermine adherence..
Am J Health Promot. 26(1), 6-9.
(2011).
(2011). Can HPV testing replace the pap smear?.
Ann N Y Acad Sci. 1205, 51-6.
(2010). Effect of type-specific human papillomavirus incidence on screening performance and cost..
Int J Gynecol Cancer. 20(2), 276-82.
(2010). Frequent presence of incomplete HPV16 E7 ORFs in lung carcinomas: memories of viral infection..
J Clin Virol. 49(3), 169-74.
(2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study..
Lancet Oncol. 11(11), 1048-56.
(2010). Awareness of human papillomavirus infection, testing and vaccination in midwives and midwifery students in Greece..
J Obstet Gynaecol. 29(6), 542-6.
(2009). Prevalence and distribution of high-risk human papillomavirus in Greece..
Eur J Cancer Prev. 18(6), 504-9.
(2009).